The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The use of recombinant factor VIIa in the treatment of bleeding disorders
Abstract
Recombinant factor VIIa was initially developed for the treatment of hemorrhagic episodes in hemophilic patients with inhibitors to factors VIII and IX. After its introduction, it has also been used “off-label” to enhance hemostasis in nonhemophilic patients who experience bleeding episodes not responsive to conventional therapy. Evidence so far indicates that the use of factor VIIa in hemophilic patients with inhibitors is both safe and effective. Anecdotal reports also suggest that the product is safe and effective in controlling bleeding in nonhemophilic patients. However, its use in these conditions has not been approved by the FDA, and conclusive evidence of its effectiveness from controlled clinical trials is not yet available. Several questions pertaining to the use of factor VIIa require further investigation, including the mechanism of action; the optimal dose; definitive indications; ultimate safety; and laboratory tests for monitoring therapy. (Blood. 2004;104:3858-3864)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meng, Z. H., Wolberg, A. S., Monroe, D. M., & Hoffman, M. (2003) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000066184.20808.a5 · Cited by 475
Self-citationTreatment of traumatic bleeding with recombinant factor VIIa
Kenet, G., Walden, R., Eldad, A., & Martinowitz, U. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05155-7 · Cited by 458
Gilchrist, G., Hoots, W. K., Cooper, H., Gastineau, D., & Shapiro, A. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615357 · Cited by 368
Aledort, L., Beardsley, D., Cooper, H., Davignon, G., Ewenstein, B., Gilchrist, G., Gill, J., Glader, B., Hoots, W. K., Kisker, C. T., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615388 · Cited by 354
Abshire, T., & Kenet, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00759.x · Cited by 314
Sjamsoedin, L. J. M., Heijnen, L., Mauser-Bunschoten, E. P., van Geijlswijk, J. L., van Houwelingen, H., van Asten, P., & Sixma, J. J. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109243051301 · Cited by 304
Deveras, R. A. E., & Kessler, C. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-11-200212030-00009 · Cited by 274
Chemokines: Roles in leukocyte development, trafficking, and effector function
Ono, S. J., Nakamura, T., Miyazaki, D., Ohbayashi, M., Dawson, M., & Toda, M. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1594 · Cited by 257
Pharmacokinetics and pharmacodynamics of recombinant factor VIIa
Lindley, C. M., Sawyer, W. T., Macik, B. G., Lusher, J., Harrison, J. F., Baird-Cox, K., Birch, K., Glazer, S., & Roberts, H. R. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.80 · Cited by 255
Self-citationCritical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Lynch, J. P., Xue, Y. Y., Berlin, A., Ross, D. J., Kunkel, S. L., Charo, I. F., & Strieter, R. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12214 · Cited by 255
Cited by
Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.183689 · Cited by 1,125
Boffard, K. D., Riou, B., Warren, B., Choong, P. I. T., Rizoli, S., Rossaint, R., Axelsen, M., & Kluger, Y. (2005) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000171453.37949.b7 · Cited by 780
Prevention and Treatment of Major Blood Loss
Mannucci, P. M., & Levi, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067742 · Cited by 494
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Huth-Kuhne, A., Baudo, F., Collins, P., Ingerslev, J., Kessler, C. M., Levesque, H., Castellano, M. E. M., Shima, M., & St-Louis, J. (2009) · Haematologica · doi:10.3324/haematol.2008.001743 · Cited by 433
Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.183689 · Cited by 357
Metadata
- Authors
- Roberts, H. R., Monroe, D. M., & White, G. C.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-12-15
- Volume
- 104
- Issue
- 13
- Pages
- 3858-3864
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2030183201
- Cited by
- 275
- References
- 34
- FWCI
- 18.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The use of recombinant factor VIIa in the treatment of bleeding disorders. https://app.cochat.ai/papers/10.1182/blood-2004-06-2223
- The paper
- Roberts, H. R., Monroe, D. M., & White, G. C. (2004). The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood. https://doi.org/10.1182/blood-2004-06-2223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.